Clinical versus Genetic Diagnosis of Cystic Fibrosis in High Risk Egyptian Children | ||||
Benha Journal of Applied Sciences | ||||
Article 10, Volume 9, Issue 6, June 2024, Page 63-72 PDF (405.73 K) | ||||
Document Type: Review Articles | ||||
DOI: 10.21608/bjas.2024.299826.1441 | ||||
![]() | ||||
Authors | ||||
Eman Rateb Abd Al-Monaem1; Doaa Refaey Soliman2; Waleed Elsayed Abdulghany3; Hala T. El-Bassyouni4; Ekram Fateen5; Asmaa Rashad Sheta ![]() | ||||
1Professor of Pediatrics Faculty of Medicine - Banha University | ||||
2Pediatric department, Benha faculty of medicine, Benha University, Egypt. | ||||
3Pediatric department, Benha faculty of medicine, Benha University, Egypt | ||||
4Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre,Cairo, Egypt. | ||||
5Biochemical Genetics Department, National Research Centre, Cairo, Egypt | ||||
6M.B.B.Ch. Faculty of Medicine, Alexandria University, Egypt | ||||
7Medical Molecular Genetics Department, National Research Centre, Cairo, Egypt. | ||||
Abstract | ||||
Background: Cystic fibrosis (CF) is a hereditary disorder affecting primarily the respiratory and digestive systems, caused by mutations in the CFTR gene. Globally, CF is a significant cause of morbidity and mortality, especially prevalent among populations of European descent. In the Middle East, including Egypt, the prevalence is less well-documented, leading to potential diagnostic challenges and delays. Objective: This comprehensive review aims to explore the clinical and molecular diagnosis of cystic fibrosis, with a particular focus on the application of these diagnostic methods in a sample of Egyptian children. The review seeks to provide an in-depth analysis of current practices, highlight unique diagnostic challenges, and suggest improvements for the Egyptian healthcare context. Conclusions: A combined clinical and molecular diagnostic approach is crucial for the accurate and early diagnosis of cystic fibrosis. While clinical methods remain essential, molecular diagnostics provide a deeper understanding of the genetic basis of CF, enabling personalized treatment strategies. For Egyptian children, where specific mutations may be more prevalent, adopting a comprehensive diagnostic protocol is imperative. The review highlights the need for improved screening programs, enhanced genetic research, and public health strategies to better manage CF in Egypt and similar regions. Future research should focus on expanding molecular diagnostic capabilities and developing tailored treatment approaches. | ||||
Keywords | ||||
Cystic fibrosis; Clinical; Molecular; Diagnosis | ||||
Statistics Article View: 272 PDF Download: 171 |
||||